Medivie Therapeutic Ltd
Medivie Therapeutic Limited develops and markets dental devices. It offers Laboraide, a dental device that is placed between the woman's lower and upper jaw during birth, which allows the relaxation of the jaw, neck, and head muscles through the flow of oxygen to the muscles. The company also develops modular pacifiers that enables development of mouth structure and prevent future damage to the c… Read more
Medivie Therapeutic Ltd (MDVI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2021: 0.217x
Based on the latest financial reports, Medivie Therapeutic Ltd (MDVI) has a cash flow conversion efficiency ratio of 0.217x as of June 2021.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-966.00K) by net assets (ILA-4.46 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medivie Therapeutic Ltd - Cash Flow Conversion Efficiency Trend (2010–2020)
This chart illustrates how Medivie Therapeutic Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medivie Therapeutic Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medivie Therapeutic Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PZU (7PZ.SG)
STU:7PZ
|
0.107x |
|
BURBERRY GROUP
BE:BB2
|
N/A |
|
Akoustis Technologies, Inc.
NASDAQ:AKTSQ
|
0.187x |
|
Orbite Technologies Inc
PINK:EORBF
|
-0.013x |
|
CELLAVISION
BE:C26
|
0.053x |
|
COSTAMARE
BE:LCM
|
0.049x |
|
Formuepleje Fokus Variabel Rente Plus KL
CO:FPKVRP
|
N/A |
|
Cerveceria San Juan S.A. (I share)
LIM:SNJUANI1
|
N/A |
Annual Cash Flow Conversion Efficiency for Medivie Therapeutic Ltd (2010–2020)
The table below shows the annual cash flow conversion efficiency of Medivie Therapeutic Ltd from 2010 to 2020.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2020-12-31 | ILA3.73 Million | ILA-3.88 Million | -1.041x | -81.64% |
| 2019-12-31 | ILA5.88 Million | ILA-3.37 Million | -0.573x | -38.84% |
| 2018-12-31 | ILA12.18 Million | ILA-5.03 Million | -0.413x | -127.05% |
| 2017-12-31 | ILA16.26 Million | ILA-2.96 Million | -0.182x | +97.06% |
| 2016-12-31 | ILA577.00K | ILA-3.57 Million | -6.194x | -192.21% |
| 2015-12-31 | ILA-527.00K | ILA-3.54 Million | 6.717x | +605.14% |
| 2014-12-31 | ILA2.26 Million | ILA-3.00 Million | -1.330x | -172.72% |
| 2013-12-31 | ILA-1.52 Million | ILA-2.79 Million | 1.829x | +117.83% |
| 2012-12-31 | ILA1.22 Million | ILA-12.52 Million | -10.254x | -172.59% |
| 2011-12-31 | ILA3.65 Million | ILA-13.74 Million | -3.762x | -321.61% |
| 2010-12-31 | ILA-5.68 Million | ILA-9.65 Million | 1.697x | -- |